13 completed. 13 Phase 2, 4 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 13 | Completed 13 |
| Phase 1 | 4 | Completed 4 |
Follow Neoplasm: new trials by email Literature Review of Neoplasm trials Research Report on Neoplasm
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Evaluate the Clinical Efficacy of JNJ-42756493 (Erdafitinib), A Pan-Fibroblast Growth Factor Receptor (FGFR) Tyrosine Kinase Inhibitor, In Asian Participants With Advanced Non-Small-Cell Lung Cancer, Urothelial Cancer, Esophageal Cancer Or Cholangiocarcinoma Erdafitinib - Neoplasm | Phase 2 | Completed | Janssen Research & Development, LLC | 35 | 2016-07-08 | 2025-04-27 |
| Study to Find a Safe Dose and Show Early Clinical Activity of Weekly Nab-paclitaxel in Pediatric Patients With Recurrent/ Refractory Solid Tumors nab-paclitaxel - Neuroblastoma, Rhabdomyosarcoma | Phase 1 / Phase 2 | Completed | Celgene | 107 | 2013-12-04 | 2019-12-27 |
| Study of Pegylated Human Recombinant Arginase for Liver Cancer (BCT-100-002) Pegylated Recombinant Human Arginase I - Neoplasm, Hepatocellular Carcinoma | Phase 1 / Phase 2 | Completed | Bio-Cancer Treatment International Limited | 20 | 2010-03-01 | 2012-03-14 |
| Study of ADI-PEG 20 in Patients With Advanced Melanoma ADI PEG 20 - Metastatic Melanoma, Skin Cancer | Phase 1 / Phase 2 | Completed | Ludwig Institute for Cancer Research | 31 | 2007-07-01 | 2022-10-25 |
| MK2461 Phase I/II Study in Patients With Advanced Solid Tumors (MK-2461-002 AM1)(COMPLETED) MK2461 - Neoplasm | Phase 1 / Phase 2 | Completed | Merck Sharp & Dohme LLC | 26 | 2007-06-01 | 2015-03-31 |
| PTK787 in Patients With Advanced Metastatic Pancreatic Adenocarcinoma PTK787/ZK222584 - Neoplasm | Phase 2 | Completed | Pancreatic Cancer Research Team | 67 | 2005-12-01 | 2012-05-09 |
| Erbitux (Cetuximab) Given Alone to Patients With EGFR-Negative Metastatic Colon or Rectal Cancer That is Refractory to Chemotherapy cetuximab - Colorectal Neoplasms, Metastases | Phase 2 | Completed | Eli Lilly and Company | 87 | 2004-10-01 | 2011-05-25 |
| Extension Program for Bay 43-9006 Nexavar (Sorafenib, BAY43-9006) - Neoplasm, Metastasis | Phase 2 | Completed | Bayer | 9 | 2002-12-01 | 2014-12-23 |
| Study of Karenitecin (BNP1350) to Treat Malignant Melanoma Karenitecin (BNP1350) - Melanoma, Neoplasm | Phase 2 | Completed | BioNumerik Pharmaceuticals, Inc. | 46 | 2002-05-01 | 2020-03-12 |
| A Pilot Study to Investigate the Clinical Utility of the Peregrine Monte Carlo Dose Calculation System for Radiation Therapy Treatment Planning Radiotherapy - Neoplasm | Phase 2 | Completed | National Cancer Institute (NCI) | 140 | 1999-05-01 | 2008-03-04 |
| Trafficking of Indium-III-Labeled Cultured Immune Cells in Patients Undergoing Immunotherapy for Advanced Cancer Gamma-camera imaging, Low-risk biopsy - Neoplasm | Phase 2 | Completed | National Cancer Institute (NCI) | 100 | 1997-12-01 | 2008-03-04 |
| Total Body Irradiation for Bone Marrow Transplants: Collaborative Efforts collaboration - Neoplasm | Phase 2 | Completed | National Cancer Institute (NCI) | 100 | 1994-10-01 | 2008-03-04 |
| Effectiveness of the FairCare System for Patients With Advanced Illness End of life care coordination, FairCare System - Terminal Care, Neoplasm | Phase 2 | Completed | US Department of Veterans Affairs | 140 | 2015-04-07 |
Neoplasms (13) · Melanoma (3) · Neoplasm Metastasis (3) · Acrocephalosyndactylia (1) · Adenocarcinoma (1) · Breast Neoplasms (1) · Carcinoma, Hepatocellular (1) · Carcinoma, Non-Small-Cell Lung (1) · Cholangiocarcinoma (1) · Colorectal Neoplasms (1) · Dermatofibrosarcoma (1) · Esophageal Neoplasms (1) · Fibrosarcoma (1) · Histiocytoma (1) · Leukemia (1)
Neoplasms by Histologic Type (7) · Neoplasms by Site (7) · Neoplasms, Glandular and Epithelial (4) · Skin Diseases (4) · Skin and Connective Tissue Diseases (4) · Carcinoma (3) · Digestive System Diseases (3) · Digestive System Neoplasms (3) · Neoplasms, Germ Cell and Embryonal (3) · Neoplasms, Nerve Tissue (3) · Neoplastic Processes (3) · Neuroectodermal Tumors (3) · Neuroendocrine Tumors (3) · Nevi and Melanomas (3) · Pathologic Processes (3)
130-nm albumin-bound paclitaxel (1) · 5H-benzo(4,5)cyclohepta(1,2-b)pyridin-5-one (1) · ADI PEG20 (1) · Albumin-Bound Paclitaxel (1) · BCT-100 (1) · Bevacizumab (1) · Cetuximab (1) · Intersectoral Collaboration (1) · Radiotherapy (1) · Sorafenib (1) · cositecan (1) · erdafitinib (1) · vatalanib (1)
National Cancer Institute (NCI) (3) · Bayer (1) · Bio-Cancer Treatment International Limited (1) · BioNumerik Pharmaceuticals, Inc. (1) · Celgene (1) · Eli Lilly and Company (1) · Janssen Research & Development, LLC (1) · Ludwig Institute for Cancer Research (1) · Merck Sharp & Dohme LLC (1) · Pancreatic Cancer Research Team (1) · US Department of Veterans Affairs (1)
United States (10) · Canada (3) · Belgium (1) · China (1) · France (1) · Germany (1) · Hong Kong (1) · Italy (1) · South Korea (1) · Spain (1) · Switzerland (1) · Taiwan (1) · United Kingdom (1)
Anna Pavlick, DO (1) · Gary Schwartz, MD (1) · Ileana Elias, M.D. (1) · Jedd Wolchok, MD, PhD (1) · Mollie Shulan, MD (1) · Ronnie TP Poon, Prof (1) · Tomislav Dragovich, MD, PhD (1)
PMID 22864522, PMID 31401903, PMID 32554315, PMID 33856599, PMID 39138436